📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Disruptive innovation in rheumatology: new networks of global public-private partnerships are needed to take advantage of scientific progress. (2020)

First Author: Huizinga TW

Attributed to: Maximising Therapeutic Utility for Rheumatoid Arthritis using genetic and genomic tissue responses to stratify medicines. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/annrheumdis-2019-216846

PubMed Identifier: 32139419

Publication URI: http://europepmc.org/abstract/MED/32139419

Type: Journal Article/Review

Volume: 79

Parent Publication: Annals of the rheumatic diseases

Issue: 5

ISSN: 0003-4967